Assets, Current of Universe Pharmaceuticals INC from 30 Sep 2020 to 30 Sep 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
- Summary
-
Universe Pharmaceuticals INC quarterly Assets, Current in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
- Universe Pharmaceuticals INC Assets, Current for the quarter ending 30 Sep 2025 was $53,603,675, a 3.8% increase year-over-year.
- Source SEC data
- View on sec.gov
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Change (%)
Universe Pharmaceuticals INC Quarterly Assets, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | $53,603,675 | +$1,965,891 | +3.8% | 30 Sep 2025 | 20-F | 29 Jan 2026 | 2025 | FY |
| Q3 2024 | $51,637,784 | +$26,368,078 | +104% | 30 Sep 2024 | 20-F | 29 Jan 2026 | 2025 | FY |
| Q1 2024 | $33,530,133 | -$18,985,080 | -36% | 31 Mar 2024 | 6-K | 20 Sep 2024 | 2024 | Q2 |
| Q3 2023 | $25,269,706 | -$16,235,974 | -39% | 30 Sep 2023 | 20-F | 29 Apr 2025 | 2024 | FY |
| Q1 2023 | $52,515,213 | +$854,430 | +1.7% | 31 Mar 2023 | 6-K | 31 Aug 2023 | 2023 | Q2 |
| Q3 2022 | $41,505,680 | -$8,975,384 | -18% | 30 Sep 2022 | 20-F | 30 Jan 2024 | 2023 | FY |
| Q1 2022 | $51,660,783 | 31 Mar 2022 | 6-K | 16 Aug 2022 | ||||
| Q3 2021 | $50,481,064 | +$27,201,143 | +117% | 30 Sep 2021 | 20-F | 10 Feb 2023 | 2022 | FY |
| Q3 2020 | $23,279,921 | 30 Sep 2020 | 20-F | 31 Jan 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.